Showing results (481-490 of 3,769) with videos related to

Sort By:
Pageof 377
Radiation Oncology (London, England)|May 14, 2013
Expression of pAkt affects p53 codon 72 polymorphism-based prediction of response to radiotherapy in nasopharyngeal carcinomaXiaoxue Xie, Hui Wang, Hekun Jin, et al.
Radiation Oncology (London, England)|May 16, 2013
Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beamsMingzan Zhuang, Tuodan Zhang, Zhijian Chen, et al.
Radiation Oncology (London, England)|April 11, 2013
Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early resultsShafak Aluwini, Peter van Rooij, Mischa Hoogeman, et al.
Radiation Oncology (London, England)|April 27, 2013
Radiosensitivity in breast cancer assessed by the histone γ-H2AX and 53BP1 fociCholpon S Djuzenova, Ines Elsner, Astrid Katzer, et al.
Radiation Oncology (London, England)|April 27, 2013
Vascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610Larry Pan, Seunghee Baek, Pamela R Edmonds, et al.
Radiation Oncology (London, England)|April 23, 2013
Re-irradiation of recurrent head and neck carcinomas: comparison of robust intensity modulated proton therapy treatment plans with helical tomotherapyMartin Stuschke, Andreas Kaiser, Jehad Abu-Jawad, et al.
Radiation Oncology (London, England)|March 19, 2013
Determination of the α/β ratio for the normal liver on the basis of radiation-induced hepatic toxicities in patients with hepatocellular carcinomaSeok Hyun Son, Hong Seok Jang, Hyochun Lee, et al.
Radiation Oncology (London, England)|March 19, 2013
Hippocampal avoidance with volumetric modulated arc therapy in melanoma brain metastases - the first Australian experienceRaef Awad, Gerald Fogarty, Angela Hong, et al.
Radiation Oncology (London, England)|March 19, 2013
DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)--a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volumeKarl Wurstbauer, Heinz Deutschmann, Karin Dagn, et al.
Radiation Oncology (London, England)|March 19, 2013
Evaluation the consistency of location of moist desquamation and skin high dose area for breast cancer patients receiving adjuvant radiotherapy after breast conservative surgeryLi-Min Sun, Eng-Yen Huang, Ji-An Liang, et al.
Pageof 377